Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 1999, p. 1794-1797, Vol. 65, No. 4
Central Virology Laboratory,
Received 20 May 1998/Accepted 28 January 1999
We describe a simple, cost-efficient, double-selective method for
isolation of wild-type poliovirus from sewage samples containing vaccine polioviruses and other enteroviruses, with a detection limit of
18 to 50 PFU per 1 to 2 liters of sewage. By this method we were able
to process 1,700 sewage samples collected between 1991 and 1996, from
which 10,472 plaques were isolated, 41 of them being identified as
wild-type polioviruses.
Environmental surveillance has been
recognized as one of the methods which can be used to monitor the
circulation of wild-type poliovirus in populations, for evaluation of
the effectiveness of polio immunization, and for epidemiological
investigations (3, 10, 11, 14, 19, 21, 26). In Israel,
environmental surveillance was implemented in 1989 following an
outbreak of poliomyelitis (9, 24, 25). Laboratory analysis
of sewage samples involves several steps, for which various protocols
were developed (1, 2, 8, 14, 22, 28). The presence of oral
polio vaccine and nonpoliovirus enteroviruses (NPEV) often complicates
such protocols. We therefore developed a double-selective tissue
culture system based on the preferential growth of polioviruses on
HEp-2 cells compared with NPEV (13) and selection against vaccine-derived polioviruses at 40°C (18).
Raw sewage samples were collected from central sewage treatment
facilities of 36 communities all over the country by either automatic
composite sampling over 24 h, manual "grab" sampling every
half hour during the two peak-capacity morning hours, or continuous
absorption sampling by placement of a gauze pad in the sewage stream
for 24 to 48 h. One to two liters of sewage or the soaked gauze
pads were kept at 4°C and then treated within 1 to 13 days of collection.
For virus extraction, the samples were allowed to settle for at least
24 h at 4°C. Most of the top (aqueous) phase was discarded, and
the bottom 250 ml, including sediment, was retained. Virus extraction
was performed as initially described by Berg et al. (1, 2).
Twenty milliliters of Freon 113, 30 ml of glycine buffer (pH 9.0), and
0.5 g of Bentonite were added to the sewage sample, which was then
homogenized for 1 to 2 min at low speed and sedimented for 20 min at
4,000 rpm (6,000 × g) and 4°C. A 100-ml portion of
the supernatant was kept and mixed with 4 ml of 10× concentrated
tissue culture medium M199 supplemented with antibiotics (final
concentrations: penicillin, 400 U/ml; streptomycin, 0.8 mg/ml; nystatin
(Mycostatin), 50 U/ml; and neomycin, 0.5 mg/ml). Sewage samples
collected on gauze pads were placed in containers with 100 to 200 ml of
saline (enough to cover the pad), 20 ml of Freon 113, 30 ml of glycine
buffer (pH 9.0), and 0.5 g of Bentonite. The container was shaken
vigorously for 30 min, the gauze pad was removed, and the solution was
treated in the same way as the liquid samples. The samples were used to
inoculate tissue cultures (see below). If no viruses were
isolated, 40 ml of the sample was subjected to ultracentrifugation at
4°C in a Beckman L7 ultracentrifuge with an SW28 rotor at 27,000 rpm
(150,000 × g). The pellet was resuspended in 14 ml of
M199 medium containing all antibiotics. If too many plaques were found,
the sample was diluted and reinoculated.
BGM (Buffalo green monkey) cells (6) were used for the
initial isolation of enterovirus plaques. The cells were maintained in
M199 medium containing 10% fetal calf serum. Each of three 10-cm
tissue culture plates with BGM cells was inoculated with 4.5 ml of the
treated sewage sample. The rest of the treated sample was stored at
HEp-2 (human larynx carcinoma) cells were used for selection of
wild-type poliovirus. The cells were plated at 2 × 105/ml in tissue culture tubes and grown in Eagle's
minimal essential medium containing 10% fetal calf serum and
antibiotics at 37°C and permitted to form monolayers. Plaques
isolated on BGM cells were collected into 0.2 ml of M199 medium and
transferred to the HEp-2 tubes and incubated at 40°C in 5%
CO2 for 5 days in a sealed incubator to maintain constant
temperature. Tubes showing cytopathic effect (CPE) were subpassaged
back on BGM cells and analyzed by microneutralization assays for
identification of viral isolates according to standard protocols
(28). Polyclonal antibodies were used for virus typing, and
monoclonal antibodies were used for intratypic differentiation
between wild-type and vaccine strains. The monoclonal antibodies were
supplied by Radu Crainic, Pasteur Institute, Paris (5, 27).
We have evaluated every step in our protocol. The fractionation of
virus particles in sewage samples was examined to reassess the results
of previous studies (1, 2), which showed that the organic
and particulate materials in an environmental sample are highly
enriched in virus particles. We have compared the number of enterovirus
plaques obtained on BGM cells after plating 15-ml extracts from the
250-ml bottom phases (containing most of the organic material) with the
number obtained after plating extracts from the 750-ml top phases of 15 randomly selected, 1-liter sewage samples. The average numbers of
plaques per milliliter obtained were 0.58 and 0.30 from the bottom and
the top phases, respectively. Thus, on average, there were 145 PFU in
the 250-ml bottom phases and 225 PFU in the 750-ml top phases, which
corresponds to 40% and 60% in the bottom and top phases, respectively.
To reevaluate the selective power of HEp-2 cells in comparison to BGM
cells (13, 28) and to obtain appropriate assay conditions, we inoculated HEp-2 and BGM cells concomitantly with six NPEV strains The RCT (reproductive capacity at supraoptimal temperature) marker is
not a definitive marker, and when used as a selector it will allow
growth of about 1% of vaccine-derived type 1 and 2 isolates and 30%
of type 3 isolates while selecting against 30 to 35% of the wild-type
1,2 and 3 isolates (18). However, it can provide a fast and
easy way for screening a large number of isolates. We have not
reassessed the selectivity of the RCT marker, since it is well established.
We have combined the two selective tools, growth on HEp-2 cells and
growth at 40°C, to eliminate the high background of NPEV and
vaccine-derived polioviruses by propagation of plaque-purified enteroviruses on HEp-2 cells at 40°C for 5 days. Only isolates which
grew at these conditions were further analyzed.
To assess the detection limit of our isolation and double-selection
protocol, we performed a reconstruction experiment. Half of each of the
bottom phases from three arbitrary sewage samples (with varied volumes)
were spiked with 100 50% tissue culture infective doses
(TCID50) (approximately 100 PFU) of wild poliovirus type 1, while the second half remained untreated. Both groups were processed
concomitantly according to the standard protocol, and each plaque which
passed the selection of HEp-2 cells at 40°C was further identified as
a poliovirus or NPEV. When the nonspiked group of samples was found to
be negative for wild-type poliovirus, we could consider the poliovirus
plaques obtained from the spiked samples as resulting only from the
spiking virus. The results of this experiment are shown in Table
2. The average number of poliovirus type
1 plaques obtained from the spiked samples was 5, which corresponds to
a 5% recovery rate. If a 40-ml sample was concentrated by
ultracentrifugation and inoculated instead of the 14.5 ml of
unconcentrated sample used in the standard protocol, the recovery rate
increased to 14%. This means that the bottom phase of a sewage sample
must contain at least 20 PFU (100%) of wild-type poliovirus to meet
the minimum of one plaque detectable after processing (5%), and taking
into account the distribution of virus between the bottom and the top
phases calculated above (40% and 60%, respectively) it implies that
the entire sewage sample should contain at least 50 PFU (or 18 PFU if
concentration of the extract by ultracentrifugation is to be used).
Thus, the overall detection limit of our standard protocol was 18 to 50 PFU per sewage sample.
0099-2240/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Double-Selective Tissue Culture System for Isolation of
Wild-Type Poliovirus from Sewage Applied in a Long-Term
Environmental Surveillance
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
20°C. Enterovirus plaques were isolated by standard protocols
(9).
Echovirus 3, Echovirus 7, Echovirus 9, Echovirus 30, Coxsackievirus A21, and Coxsackievirus B3 (wild type isolates from our
laboratory)
and the three wild-prototype polioviruses Mahoney, MEF-1,
and Saukett (obtained from Radu Crainic, Pasteur Institute, Paris),
which were titrated to end point at 37°C. The results are shown in
Table 1. This experiment confirmed that
HEp-2 cells are highly permissive for growth of wild-type polioviruses
and less permissive for growth of most other NPEV. Thus, a significant
degree of selectivity could be obtained if the cultures were maintained
for only 5 days. However, the actual level of selectivity for unknown
wild-type enteroviruses could be assessed only during field trials, as
described below.
TABLE 1.
Replication of wild-type polioviruses and
enteroviruses on BGM and HEp-2 cells
TABLE 2.
Recovery rates of wild poliovirus type 1 from
sewage samples
The new protocol was implemented in mid-1991 and has been in use without any significant changes between 1991 and 1996. A flow chart of the entire protocol is shown in Fig. 1. Completion of the entire protocol took between 3 and 5 weeks. However, the first indication that a wild-type poliovirus was found in a sewage sample could be obtained between 10 and 14 days after inoculation.
|
The selective protocol allowed us to increase the number of plaques
screened by the double selection, thereby increasing the chances of
isolating wild-type poliovirus. A comparative evaluation of the
efficiencies of the protocols used before 1991 (selection for wild-type
poliovirus on BGM cells at 40°C) and since mid-1991 (selection for
wild-type poliovirus on HEp-2 cells at 40°C) is based on the
information presented in Table 3. Between
1992 and 1996, 1,545 sewage samples were processed by the new protocol, while about 253 were processed by the old method (in 1989 and 1990).
During 1991 the new protocol was first introduced and continuously changed and improved, and thus we did not include this year in the
statistics.
|
The average number of plaques screened annually by the selective system increased by 1.8-fold, from 1,095 in 1989 and 1990 to 1978 between 1992 and 1996. In contrast, the average number of isolates subjected to neutralization analysis each year was reduced from 222 in 1989 and 1990 to 26 between 1992 and 1996, a ninefold decrease. This dramatic decrease resulted primarily from the elimination of the NPEV by selective propagation on HEp-2 cells. The average annual number of vaccine-derived poliovirus isolates was small before and after 1991. (During 1991 we deliberately isolated vaccine-derived strains at 37°C as part of the assessment of the new protocol.) We did not expect to find changes in this parameter because vaccine-derived polioviruses grow equally well on BGM and HEp-2 cells (data not shown) and are selected against by growth at 40°C, a step which was included in both the old and the new protocols. Between 1989 and 1996 we isolated 41 wild-type poliovirus plaques from 17 sewage samples.
The goal of developing a fast and cost-efficient method for a continuous, country-wide and years-long environmental surveillance for wild-type poliovirus has been achieved. The use of 250 ml from the bottom phase after settling, which is enriched in organic material and contains 40% of the viral particles, rather than the entire 1- to 2-liter sample allowed fast processing of several samples in parallel without the need for special equipment. Addition of concentration steps by various methods, such as flocculation, adsorption on aluminum hydroxide, or polyethylene glycol (PEG) precipitation (10, 17, 23, 26), would have complicated the protocol, which could become more labor-intensive. Recently, we have tested a protocol that included concentration of virus from the top phase by PEG precipitation, which required centrifugation of large volumes and several extraction steps. This protocol aims at obtaining all of the virus particles found in a sewage sample. However, in our hands only 18% of the enterovirus PFU were recovered (data not shown).
We continue to examine various ways to further concentrate our samples in order to increase the recovery rate. We prefer to avoid concentration of large volumes and too many extraction steps to keep our protocol as simple and handy as possible.
For virus isolation, the use of the RCT marker (18),
combined with the selective power of the HEp-2 cell line
(13), yielded a double-selective system, which
substantially reduced the number of plaques analyzed by neutralization
assays and allowed us to screen practically every enterovirus isolate.
There is still a nonnegligible chance that some wild-type poliovirus
strains with an RCT
phenotype will be lost during this
selection process. However, the proportion (30 to 35%) is far less
than the proportion of isolates that would have been neglected (90%)
without the 40°C selection, because it would have taken too much time
and effort to analyze all of them.
Since 1988 no clinical cases of poliomyelitis have occurred in Israel or the Palestinian territories in spite of the clear evidence of wild-type poliovirus circulation obtained through the environmental surveillance. All but one of the wild-type isolates were poliovirus type 1, and they were detected in four episodes, which were termed silent outbreaks: one in October 1990 (type 3), the second between May and October 1991, the third between October 1994 and June 1995, and the fourth in December 1996. This suggests that our technique is sensitive enough to detect poliovirus which circulates in the population at a relatively low intensity that is not sufficient to cause morbidity in a well-vaccinated population. A rough calculation (11a) suggests that in industrialized countries examination of about 1 ml of a sewage sample even without concentration theoretically allows detection of poliovirus circulation in a population of 10,000 people if about 100 individuals are excreting the virus. Addition of a concentration step is much needed to detect circulation of viruses in larger communities without polio.
Our protocol is relatively simple and incorporates techniques recommended by the World Health Organization (WHO) for poliovirus isolation and identification. These techniques are available in WHO National Centers all over the world and thus are highly suitable for immediate application anywhere, including developing countries which are on the verge of eradicating poliomyelitis. In such places as the Gaza Strip the current method is sensitive enough, and it could be implemented in addition to the acute flaccid paralysis surveillance required by the WHO (28).
Today new techniques have become available, such as the initial isolation of polioviruses in recombinant mouse L-cells expressing the cloned poliovirus receptor gene (12, 15, 20). These cell lines allow isolation of polioviruses exclusively, rather than other human enteroviruses (12, 20). Other suggested innovations include the use of enzyme-linked immunosorbent assays and molecular methods instead of neutralization assays for virus identification (4, 7, 16, 23, 27). We are exploring these options as alternatives to our current methods for future application. However, only a true field trial will allow a real evaluation of their applicability in the context of continuous environmental surveillance.
| |
ACKNOWLEDGMENTS |
|---|
We thank Robert Armon, Abed Nassar, and the late Eli Katzenelson for their help in the evaluation of the extraction and selection protocols, Zehava Grossman for critically reading the manuscript, and Etti Tilles for typing it.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Central Virology Laboratory, Chaim Sheba Medical Center, Tel-Hashomer 52621, Israel. Phone: 972-3-530-2421. Fax: 972-3-530-2457. E-mail: ellamen{at}ibm.net.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Berg, G., and D. R. Dahling.
1980.
Methods for recovering viruses from river water solids.
Appl. Environ. Microbiol.
39:850 |
| 2. | Berg, G., R. S. Safferman, D. R. Dahling, D. Berman, and C. J. Hurst. 1984. Methods for recovering viruses from toxic sludges and solids, p. 8.1-8.14. In USEPA manual of methods for virology. EPA-600/4-84-013. U.S. Environmental Protection Agency, Washington, D.C. |
| 3. | Bottinger, M., and E. Herrstrom. 1992. Isolation of polioviruses from sewage and their characteristics. Experience over two decades in Sweden. Scand. J. Infect. Dis. 24:151-155[Medline]. |
| 4. | Chezzi, C., and B. D. Schoub. 1996. Differentiation between vaccine related and wild-type polioviruses using a heteroduplex mobility assay. J. Virol. Methods 62:93-102[Medline]. |
| 5. |
Crainic, R.,
P. Couillin,
B. Blondel,
N. Cabau,
A. Boué, and F. Horodniceanu.
1983.
Natural variation of poliovirus neutralization epitopes.
Infect. Immun.
41:1217-1225 |
| 6. | Dahling, D. R., G. Berg, and D. Berman. 1974. BGM, a continuous cell line more sensitive than primary Rhesus and African Green for recovery of viruses from water. Health Lab. Sci. 11(4):275-282[Medline]. |
| 7. | De, L., B. Nottay, C. F. Yang, B. P. Holloway, M. Pallansch, and O. Kew. 1995. Identification of vaccine-related polioviruses by hybridization with specific RNA probe. J. Clin. Microbiol. 33:562-571[Abstract]. |
| 8. | Grabow, W., J. C. De Villiers, B. Erasmus, D. Erasmus, and L. Engelbrecht. 1996. Viruses in waste water from an informal settlement. Proceedings of the Biennial Conference of the Water Institute of Southern Africa, Port Elizabeth, South Africa, 20 to 23 May, 1996. Water Institute of Southern Africa, Johannesburg, South Africa. |
| 9. | Grandien, M., M. Forsgren, and A. Ehrnst. 1988. Enteroviruses and reoviruses, p. 513-579. In N. J. Schmidt, and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial, and chlamidial infections, 6th ed. American Public Health Association, Washington, D.C. |
| 10. | Green, M. S., R. Handsher, D. Cohen, J. Melnick, R. Slepon, E. Mendelson, and Y. Danon. 1993. Age differences in immunity against wild and vaccine strains of poliovirus prior to the 1988 outbreak in Israel and response to booster I immunization. Vaccine 11:75-81[Medline]. |
| 11. |
Horstmann, D. M.,
J. Emmons,
L. Gimpel,
T. Subrahmanyan, and J. T. Riordan.
1973.
Enterovirus surveillance following community-wide oral poliovirus vaccination program: a seven year study.
Am. J. Epidemiol.
97:173-186 |
| 11a. | Hovi, T. Personal communication. |
| 12. |
Hovi, T., and M. Stenvik.
1994.
Selective isolation of poliovirus in recombinant murine cell line expressing the human poliovirus receptor gene.
J. Clin. Microbiol.
32:1366-1368 |
| 13. |
Johnston, S. L. G., and C. S. Siegel.
1990.
Presumptive identification of enteroviruses with RD, HEp-2, and RMK cell lines.
J. Clin. Microbiol.
28:1049-1050 |
| 14. | Kew, O., L. De, C. F. Yang, B. Nottay, and M. Pallansch. 1993. The role of virologic surveillance in the global initiative to eradicate poliomyelitis, p. 215-246. In E. Kustak (ed.), Control of virus diseases. Marcel Dekker, New York, N.Y. |
| 15. | Koike, S., H. Itoshi, I. Ise, A. Okitsu, M. Yoshida, N. Iizuka, K. Takeuzi, T. Takegami, and A. Nomoto. 1990. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:3217-3224[Medline]. |
| 16. | Marques, E., E. E. DaSilva, V. M. Dos Santos, O. Kew, and M. T. Martins. 1993. Application of the polymerase chain reaction (PCR) to poliomyelitis surveillance through the analyses of sewage samples. World J. Microbiol. Biochem. 9:566-569. |
| 17. | Martins, M. T., E. Marques, and L. A. Soares. 1982. A comparative study of methods for concentration of human enteric viruses from sewage. Water Sci. Technol. 14:273-279. |
| 18. | Nakano, J. H., M. H. Milford, M. L. Thieme, and B. Nottay. 1978. Parameters for differentiating vaccine derived and wild poliovirus strains. Prog. Med. Virol. 24:178-206[Medline]. |
| 19. |
Nelson, D. B.,
R. Circo, and A. S. Evans.
1967.
Strategic viral surveillance of sewage during and following an oral poliovirus vaccine campaign.
Am. J. Epidemiol.
86:641-652 |
| 20. | Pipkins, P. A., D. J. Wood, V. R. Racaniello, and P. D. Minor. 1993. Characterization of L cells expressing the human poliovirus receptor for specific detection of poliovirus in vitro. J. Virol. Methods 41:333-340[Medline]. |
| 21. |
Poyry, T.,
M. Stenvik, and T. Hovi.
1988.
Viruses in sewage waters during and after a poliomyelitis outbreak and subsequent nationwide oral poliovirus vaccination campaign in Finland.
Appl. Environ. Microbiol.
54:371-374 |
| 22. | Schaub, S. A., and B. P. Sagik. 1975. Association of enteroviruses with natural and artificially introduced colloidal solids in water and infectivity of solids-associated virions. Appl. Microbiol. 30:212-222[Medline]. |
| 23. | Shieh, Y. S. C., D. Wait, L. Tai, and M. D. Sobsey. 1995. Methods to remove inhibitors in sewage and other fecal wastes for enterovirus detection by the polymerase chain reaction. J. Virol. Methods 54:51-66[Medline]. |
| 24. | Slater, P. E., W. A. Orenstein, A. Morag, et al. 1990. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet 335:1192-1198[Medline]. |
| 25. | Swartz, T. A., and R. Handsher. 1993. Israel in the elimination phase of poliomyelitis. Public Health Rev. 21:99-106[Medline]. |
| 26. | Tambini, G., J. K. Andrus, E. Marques, J. Boshell, M. Pallansch, C. A. de Quadros, and O. Kew. 1993. Direct detection of wild poliovirus circulation by stool survey of healthy children and analysis of community wastewater. J. Infect. Dis. 168:1510-1514[Medline]. |
| 27. | Van der Avoort, H. G. A. M., B. Hull, T. Hovi, M. Pallansch, O. Kew, R. Crainic, D. Wood, M. Mulders, and A. Van Loon. 1995. Comparative study of five methods for intratypic differentiation of polioviruses. J. Clin. Microbiol. 33:2562-2566[Abstract]. |
| 28. | World Health Organization. 1997. Manual for the virological investigation of poliomyelitis. World Health Organization, Geneva, Switzerland. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»